Global Neuroprosthetics Market 2015-2019 - Industry research report

神経機能代替デバイスの世界市場:認知デバイス(人工内耳)、神経調節デバイス

◆タイトル:Global Neuroprosthetics Market 2015-2019 - Industry research report
◆商品コード:IRTNTR7193
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年9月30日
◆ページ数:78
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥265,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥318,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、神経機能代替デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、神経機能代替デバイスの世界市場規模及び予測、用途別分析、技術別分析、市場シェア、地域別分析、市場の成長要因、市場の課題、医療費償還シナリオ、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

・エグゼクティブサマリー
・市場概観
・業界の構造分析
・神経機能代替デバイスの世界市場:市場規模及び予測
・神経機能代替デバイスの世界市場:技術別分析
・神経機能代替デバイスの世界市場:用途別分析
・神経機能代替デバイスの世界市場:地域別分析
・市場シェア
・市場の成長要因
・市場の課題
・医療費償還シナリオ
・市場動向
・競争状況
・主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About neuroprosthetics
Neuroprosthetics are implantable devices designed by combining neuroscience and biomedical engineering. These artificial implantable devices provide electrical stimulation that improves the functionality of a diseased nervous system. These devices either are implanted inside the body or can be worn externally. These are used either to replace a lost function of the body such as cognitive ability or to treat neurological conditions such as depression, chronic pain, epilepsy, or spinal cord injuries. Based on application, neuroprosthetics are segmented into cognitive devices and neuromodulation devices. Based on technology, neuroprosthetics are segmented into SCS system, DBS system, SNS system, VNS system, and others.

Technavio’s analysts forecast the global neuroprosthetics market to grow at a CAGR of 7.08% over the period 2014-2019.

[Covered in this report]
The report covers the current scenario and the growth prospects of the global neuroprosthetics market for the period 2015-2019. To calculate the market size, we consider revenue generated from the sales of cochlear implants and neuromodulators.

Based on application, the market is segmented into the following:
• Cognitive devices (cochlear implants)
• Neuromodulation devices

Based on technology, the market is segmented into the following:
• SCS system
• DBS system
• SNS system
• VNS system
• Others (transcranial magnetic stimulation, peripheral nerve stimulation, gastric electrical stimulation, diaphragm pacing, lower esophageal sphincter stimulation, and cortical stimulation systems)

Technavio’s report, Global Neuroprosthetics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global neuroprosthetics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key regions]
• Americas
• APAC
• EMEA

[Key vendors]
• Boston Scientific
• Cochlear
• MED-EL
• Medtronic
• Sonova
• St. Jude Medical

[Other prominent vendors]
• Autonomic Technologies
• BrainGate
• electroCore
• Mainstay Medical
• NeuroPace
• Nevro
• Oticon Medical
• Soterix Medical

[Market Driver]
• Growing prevalence of neurological disorder
• For a full, detailed list, view our report

[Market challenge]
• Battery lifetime
• For a full, detailed list, view our report

[Market trend]
• Overseas expansion
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Reimbursement for neuroprosthetics
Reimbursement in US
Reimbursement in Europe
Reimbursement in APAC

PART 06: Emerging technologies in neuroprosthetics
Brain-computer interface

PART 07: Recent market approvals

PART 08: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 09: Market segmentation by application
Global neuroprosthetics market segmentation by application

PART 10: Global cognitive devices market
Market overview
Market size and forecast

PART 11: Global neuromodulation devices market
Market overview
Market size and forecast

PART 12: Market segmentation by technology
Global neuroprosthetics market segmentation by technology

PART 13: Geographical segmentation
Neuroprosthetics market in Americas
Neuroprosthetics market in EMEA
Neuroprosthetics market in APAC

PART 14: Market drivers
Increased prevalence of neurological disorders
Availability of funds for R&D
Numerous product approvals
Second-line treatment

PART 15: Impact of drivers

PART 16: Market challenges
Battery lifetime
Limited compatibility with MRI, X-ray, and ultrasound equipment
Limited reimbursement scenario
GPOs as intermediary
Stringent regulations
Cost containment

PART 17: Impact of drivers and challenges

PART 18: Market trends
Overseas expansions
Hybrid neuroprosthetic devices
Next-generation therapies for CNS disorders
Aesthetically appealing prosthetics
Use in US military

PART 19: Vendor landscape
Competitive scenario
Market share analysis 2013
Other prominent vendors

PART 20: Key vendor analysis
Boston Scientific
Cochlear
MED-EL
Medtronic
Sonova
St. Jude Medical

PART 21: Appendix
List of abbreviations

PART 22: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Reimbursement of neuroprosthetics in US
Exhibit 03: Reimbursement of neuroprosthetics in major European countries
Exhibit 04: Emerging neuroprosthetics and approval dates
Exhibit 05: Approved neuroprosthetics 2015
Exhibit 06: Global neuroprosthetics market 2014-2019 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Global neuroprosthetics market segmentation by application 2014
Exhibit 09: Global cochlear implants market 2014-2019 ($ billions)
Exhibit 10: Global neuromodulation devices market 2014-2019 ($ billions)
Exhibit 11: Global neuroprosthetics market segmentation by technology 2014
Exhibit 12: Global SCS system market 2014-2019 ($ billions)
Exhibit 13: Global DBS system market 2014-2019 ($ millions)
Exhibit 14: Global SNS system market 2014-2019 ($ millions)
Exhibit 15: Global VNS system market 2014-2019 ($ millions)
Exhibit 16: Global neuroprosthetics market segmentation by geography 2014
Exhibit 17: Neuroprosthetics market in Americas 2014-2019 ($ millions)
Exhibit 18: Neuroprosthetics market in EMEA 2014-2019 ($ billions)
Exhibit 19: Neuroprosthetics market in APAC 2014-2019 ($ billions)
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: Top vendors in cognitive devices market 2014
Exhibit 23: Cochlear: Key takeaways
Exhibit 24: MED-EL: Key takeaways
Exhibit 25: Sonova Holding: Key takeaways
Exhibit 26: Global neuromodulation devices market share analysis 2014
Exhibit 27: Medtronic: Key takeaways
Exhibit 28: Boston Scientific: Key takeaways
Exhibit 29: St. Jude Medical: Key takeaways
Exhibit 30: Cochlear: Business segmentation by revenue 2014
Exhibit 31: Cochlear: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 32: MED-EL: Product offerings
Exhibit 33: Sonova: Business segmentation
Exhibit 34: Sonova: Business segmentation by revenue 2015
Exhibit 35: Sonova: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 36: Sonova: Geographical segmentation by revenue 2014



【掲載企業】

Boston Scientific, Medtronic, St. Jude Medical, Cochlear Ltd.,Sonova Holding.,Aleva Neuroprosthetics, Atrotech, Autonomic Technologies, BrainGate, electroCore, Mainstay Medical, Med-EL, NeuroPace, Nevro, Soterix Medical, Oticon Medical.

【資料のキーワード】

神経機能代替デバイス、認知デバイス(人工内耳)、神経調節デバイス、SCSシステム、DBSシステム、SNSシステム、VNSシステム、神経機能代替技術

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[神経機能代替デバイスの世界市場:認知デバイス(人工内耳)、神経調節デバイス]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆